Literature DB >> 22086091

Interlaminar versus transforaminal epidural steroids for the treatment of subacute lumbar radicular pain: a randomized, blinded, prospective outcome study.

Christopher G Gharibo1, Gerald P Varlotta, Ellen E Rhame, En-Chia James Liu, John A Bendo, Michael D Perloff.   

Abstract

BACKGROUND: There is uncertainty in the literature over the relative effectiveness of lumbar epidural interlaminar (IL) steroid injection versus transforaminal (TF) steroid injection for lumbar radiculopathy. Most studies to date have been retrospective, or technically focused.
OBJECTIVE: To complete a randomized, blinded, prospective outcome study of the short-term benefit for IL versus TF epidural steroids for the treatment of subacute lumbar radicular pain. STUDY
DESIGN: Prospective, randomized, blinded, subacute efficacy trial.
SETTING: Tertiary care pain management center, major metropolitan city, United States.
METHODS: After institutional review board approval, 42 age-matched patients with similar lower back pain and unilateral radicular symptoms were enrolled and randomized in a patient and evaluating physician blinded trial to IL or TF epidural steroids from 2007 through 2009. Prior to intervention and 10-16 days after injection, each participant was evaluated by questionnaire and physical exam by an independent physician. All injections were performed by the same physician. Thirty-eight participants completed the study, 18 in the IL group and 20 in the TF group. Four participants required a repeat injection, and 2 participants crossed over to the alternative injection type (IL to TF).
RESULTS: Overall, physical exam, diagnostic testing, disability, activity, depression measures, and opioid pill use were similar between the 2 groups, both pre-injection baseline and post-injection improvement. In primary outcomes, the post-injection follow-up Numeric Rating Scale (NRS) was more greatly reduced in the TF group. The NRS decreased from 7.0 ± 1.9 to 3.9 ± 3.1 (mean values +/- standard deviation) in the IL group and 6.4 ± 2.1 to 1.7 ± 1.4 in the TF group. The Oswestry Disability Index was reduced from 37.5 ± 12.6 to 19.0 ± 16.7 in the IL group and 38.3 ± 6.4 to 21.6 ± 16.8 in the TF group. In secondary outcomes, the depression scale was reduced from 4.39 ± 3.22 to 2.28 ± 3.20 in the IL group and 4.10 ± 1.94 to 1.65 ± 1.63 in the TF group. Walking tolerance was increased from 8.1 ± 4.6 blocks to 10.6 ± 4.4 in the IL group and 8.9 ± 5.3 blocks to 11.8 ± 4.2 in the TF group. LIMITATIONS: The study did not examine long-term outcomes. A single experienced interventionalist performed all injections.
CONCLUSION: Results suggest that patients may experience greater subjective relief, at least initially, from TF epidural steroid injections over IL. However, more objective, and likely subacute, therapeutic effects are similar.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22086091

Source DB:  PubMed          Journal:  Pain Physician        ISSN: 1533-3159            Impact factor:   4.965


  11 in total

Review 1.  Do Epidural Injections Provide Short- and Long-term Relief for Lumbar Disc Herniation? A Systematic Review.

Authors:  Laxmaiah Manchikanti; Ramsin M Benyamin; Frank J E Falco; Alan D Kaye; Joshua A Hirsch
Journal:  Clin Orthop Relat Res       Date:  2015-06       Impact factor: 4.176

2.  Transcutaneous Electrical Acupoint Stimulation for Moderate to Severe Pain in Hepatocellular Carcinoma: A Protocol for a Randomized Controlled Trial.

Authors:  Pin Wu; Lu Zhu; Shi-Yu Zheng; Jun-Xiong Li; Meng-Die Wu; Wen-Jia Wang; Yu-Chao Hou; Jing Li; Huan-Gan Wu
Journal:  J Pain Res       Date:  2022-07-06       Impact factor: 2.832

3.  Comparison of transforaminal verse interlaminar epidural steroid injection in low back pain with lumbosacral radicular pain: a meta-analysis of the literature.

Authors:  Guo Wei; Jie Liang; Bo Chen; Caisheng Zhou; Neng Ru; Jianfeng Chen; Fan Zhang
Journal:  Int Orthop       Date:  2016-05-20       Impact factor: 3.075

4.  Fluoroscopic lumbar interlaminar epidural injections in managing chronic lumbar axial or discogenic pain.

Authors:  Laxmaiah Manchikanti; Kimberly A Cash; Carla D McManus; Vidyasagar Pampati; Ramsin Benyamin
Journal:  J Pain Res       Date:  2012-08-24       Impact factor: 3.133

5.  Dexamethasone added to local lidocaine for infiltration along the spinal-epidural needle pathway decreases incidence and severity of backache after gynecological surgery.

Authors:  Wei Gao; Yi Ren; Guang Xiao Cui
Journal:  Med Sci Monit       Date:  2015-03-18

6.  Comparison of clinical efficacy in epidural steroid injections through transforaminal or parasagittal approaches.

Authors:  Ji Hee Hong; Eun Kyul Park; Ki Bum Park; Ji Hoon Park; Sung Won Jung
Journal:  Korean J Pain       Date:  2017-06-30

7.  Treatment of acute sciatica with transforaminal epidural corticosteroids and local anesthetic: design of a randomized controlled trial.

Authors:  Bastiaan C Ter Meulen; Esther T Maas; Amrita Vyas; Marinus van der Vegt; Koo de Priester; Michiel R de Boer; Maurits W van Tulder; Henry C Weinstein; Raymond W J G Ostelo
Journal:  BMC Musculoskelet Disord       Date:  2017-05-25       Impact factor: 2.362

8.  Fluoroscopic caudal epidural injections in managing chronic axial low back pain without disc herniation, radiculitis, or facet joint pain.

Authors:  Laxmaiah Manchikanti; Kimberly A Cash; Carla D McManus; Vidyasagar Pampati
Journal:  J Pain Res       Date:  2012-10-12       Impact factor: 3.133

9.  The role of thoracic medial branch blocks in managing chronic mid and upper back pain: a randomized, double-blind, active-control trial with a 2-year followup.

Authors:  Laxmaiah Manchikanti; Vijay Singh; Frank J E Falco; Kimberly A Cash; Vidyasagar Pampati; Bert Fellows
Journal:  Anesthesiol Res Pract       Date:  2012-07-19

10.  Comparison of the efficacy of transforaminal and interlaminar radicular block techniques for treating lumbar disk hernia.

Authors:  Rodrigo Rezende; Charbel Jacob Júnior; Camila Kill da Silva; Igor de Barcellos Zanon; Igor Machado Cardoso; José Lucas Batista Júnior
Journal:  Rev Bras Ortop       Date:  2015-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.